Soft Tissue Repair Market Size & Share, by Product Type (Fixation Devices, Tissue Scaffold, Cell-Therapy Based); End-User (Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Physician Office) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5530
  • Published Date: May 06, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024 - 2036

Soft Tissue Repair Market size is poised to reach USD 17 Billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of soft tissue repair devices was USD 7 Billion. The market is expanding owing to the growing prevalence of traumatic accidents such as road accidents. According to a report, roughly 1.19 million people lose their lives in vehicle crashes every year. As per estimates, about 20 to 50 million more people experience non-fatal injuries; several of them become disabled. The orthopedic injury resulting from the traffic collision was the primary cause of this disability.

In addition to these, factors that are believed to fuel the market growth of soft tissue repair are growing technological advancements which include the creation of tissue scaffolds, bioengineered grafts, and regenerative medicine methods. Patients are now given access to therapies that encourage tissue regeneration in addition to relieving pain and returning function, which speeds up recovery and improves results.


Soft Tissue Repair Market
Get more information on this report: Request Free Sample PDF

Soft Tissue Repair Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing geriatric population - As per the WHO predictions, one in six individuals worldwide will be 60 years of age or older by 2030. At this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. When people age, their physical systems age as well, including the musculoskeletal system. One may notice a decline in general quickness and movement and weaker bones and less slender muscles.

    The possibility of falls and injuries is raised as a result of these changes. Although there are more than a hundred varieties of arthritis, osteoarthritis is the most prevalent one that affects the elderly.
  • Increased incidences of obesity - According to the WHO, around the globe, 650 million adults, 340 million teenagers, and 39 million children are obese, making up over 1 billion people. It is generally accepted that obesity produces abnormal body mechanics that negatively impact joint function due to the increased stress on the skeletal system.

    One of the main risk factors for the onset and progression of osteoarthritis in load-bearing joints, such as the knee but also the hip and ankle, is obesity. Changes in gait and higher joint stress are thought to be the primary biomechanical impacts of obesity on joints. This consequently results in greater strain on the articular cartilage and may also result in increased stress in the synovial fluid, subchondral bone, and ligamentous and capsular structures of the joint. Therefore, the market demand for soft tissue repair is surging.
  • Rising prevalence of tendinitis in sports people - As the fibrous tissue that joins muscles to bones, a tendon can become inflamed and develop tendinitis. For instance, sportsmen who execute the same motion repeatedly are at risk of developing tendinitis owing to overuse and repetitive motion. Moreover, there has been growing participation of athletes which is making scope for the growth of the soft tissue repair market.

Challenges

  • Unfavorable reimbursement policies - Large sums of money must be invested in the development of new soft tissue repair treatments, and it often takes longer for such products to be approved for sale.

    The FDA, for instance, has mandated that soft tissue repair product producers acquire premarket clearance (PMA) before releasing their goods onto the market. The product must provide appropriate clinical trial data in support of this, and this data must be provided with the PMA application. With very little possibility of approval, a product must incur significant costs and take a very long time to reach the clinical trial stage and then complete the trials.
  • Lack of skilled staff may hinder the growth of the market
  • High price of the treatment may impede the market from growing

Soft Tissue Repair Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

7%

Base Year Market Size (2023)

USD 7 Billion

Forecast Year Market Size (2036)

USD 17 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Soft Tissue Repair Segmentation

Product Type (Fixation Devices, Tissue Scaffold, Cell-Therapy Based)

In soft tissue repair market, fixation devices segment is predicted to capture over 50% revenue share by 2036. The segment growth can be attributed to the growing prevalence of fractures and sports injuries. Fixation devices serve as an alternative for the bone structure and are composed of synthetic materials. As the bones heal after surgery or an injury, they serve to stabilize and support them. A wide range of ailments, such as fractures and sports injuries, may be treated with fixation devices.

Interference screws and suture anchors are a couple of the fixing tools. Suture anchors are frequently employed in arthroscopic surgery and sports medicine as essential instruments for fastening soft tissue to the bone.  Further, the interference screw is a direct tendon-to-bone interference fixing tool. By reaching out and compressing the graft with the screw threads, this common compression fixation tool fixes the graft. Thus, during the forecast period, the growing necessity for fixation devices in soft tissue repair will propel the segment's expansion.

End-User (Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Physician Office)

The hospitals & clinics segment in the soft tissue repair market is predicted to account for a share of 46% during the forecast timeframe. The segment’s growth is led by the growing number of hospitals. The number of hospitals globally as of 2021 was estimated to be approximately 164,000.  Furthermore, there has been a surge in investment in the hospital sector. Therefore, medical technology and healthcare administration techniques have become more innovative as a result of the growing investments in the field. Hence, more people are driving for orthopedic treatment in hospitals.

Furthermore, several significant medical industry companies are looking into inorganic expansion prospects. Additionally, this will likely end up resulting in more beds being added as a result of mergers and acquisitions. Therefore, this is estimated to boost the segment growth hence further influencing the market revenue.  

Our in-depth analysis of the global market includes the following segments:

     Product Type

  • Fixation Devices
  • Tissue Scaffold
  • Cell-Therapy Based

     End-user

  • Hospitals & Clinics
  • Ambulatory Surgical Centers [ASCs]
  • Physician Office

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Soft Tissue Repair Industry-Regional Synopsis

North America Market Statistics

Soft tissue repair market in the North America is anticipated to hold the largest with a share of about 35% by the end of 2036. The market growth in the region is also expected on account of the increasing expenditure on healthcare. The amount spent on health care in the United States increased by over 3% in 2022 to approximately USD 3 trillion, or over USD 13,492 per person. Furthermore, this region has the presence of key players focused on the field of soft tissue repair.

Additionally, this region has experienced significant launch of advanced products which is why the market in this region is growing. Additionally, government legislation supporting the healthcare system, the need to lower healthcare costs, and the prevalence of chronic diseases are all important factors.

APAC Market Analysis

The Asia Pacific region will also encounter enormous growth for the soft tissue repair market during the forecast period and will hold the second position owing to the rising disposable income in this region. Hence, the willingness of people to spend more on soft tissue repair treatment is growing in this region.

Furthermore, there has been continuous growth in research in this field which is also projected to dominate the market expansion. Also, this region is experiencing an upward movement in medical tourism due to the upgradation in technology. 

 

Research Nester
Soft Tissue Repair Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Soft Tissue Repair Landscape

    • 3D Systems
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Biocomposites
    • Medtronic plc
    • Stryker
    • Zimmer Biomet
    • Arthrex, Inc.
    • ConMed Corporation
    • Acumed, LLC
    • Integra LifeSciences
    • ArthroCare Corporation

     


In the News

  • 3D Systems, the premier additive manufacturing solutions partner, and Theradaptive, a biopharmaceutical firm pioneering tailored regenerative treatments, announced a commercial agreement that designates 3D Systems as Theradaptive's exclusive 3D printing partner. The businesses seek to provide a revolutionary strategy to promoting bone and tissue regeneration by coating 3D Systems' 3D-printed medical devices with Theradaptive's unique protein-based material-binding variations. This solution has the potential to improve patients' healing and consequently their results.
  • Arthrex, a global leader in minimally invasive surgical technology, revealed that its ACL TightRope implant has been cleared by the US Food and Drug Administration (FDA) for pediatric use. The TightRope implant is used to treat orthopedic injuries surgically, and it is the first and only fixation device for anterior cruciate ligament (ACL) injuries that has been certified for pediatric usage. The Arthrex all-epiphyseal approach was designed for skeletally immature patients and entails bypassing the juvenile growth plates when repairing or reconstructing the ACL.

Author Credits:  Radhika Pawar


  • Report ID: 5530
  • Published Date: May 06, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of soft tissue repair devices was over USD 7 billion.

The market size for soft tissue repair devices is projected to cross USD 17 billion by the end of 2036 expanding at a CAGR of 7% during the forecast period i.e., between 2024-2036.

The major players in the market are 3D Systems, Biocomposites, Medtronic plc, Stryker, Zimmer Biomet, Arthrex, Inc., ConMed Corporation, Acumed, LLC, Integra LifeSciences, ArthroCare Corporation, and others.

In terms of product type, the fixation devices segment is anticipated to account for the largest market share of 50% during 2024-2036.

In the year 2023, the industry size of soft tissue repair devices was over USD 7 billion.
Soft Tissue Repair Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample